References
- Ajith TA, Janardhanan KK (2001): Antioxidant and anti-inflam-matory activities of methanol extract of Phellinus rimosus (Berk) Pilat. Indian J Exp Biol 39: 1166–1169.
- Brooks PM, Day RO (1991): Nonsteroidal anti-inflammatory drugs: differences and similarities. N Engl J Med 324: 1716–1719.
- Chen AW (2001): Cultivation of the medicinal mushroom Ganoderma lucidum (Curt.:Fr) P. Karst. Reishi in North America. Mushroom World Dec: 1–9.
- Collins T (1999): Acute and chronic inflammation. In: Cotran RS, Kumar V, Collins T, eds., Textbook of Robbins Patho-logic Basis of Disease. 6th ed., Philadelphia, W.B. Sounders Company, pp. 50–51.
- de Souza MiM, Madeira A, Berti C, Krough R, Yunes RA, Cechinel-Filho V (2000): Anti-nociceptive properties of the methanolic extract obtained from Ipomoea pes-caprae (L.) R. Br. J Ethnopharmacol 69: 85–90.
- Greenwald RA (1991): Animal model for evaluation of arthritic drugs. Meth Find Clin Pharmacol 13: 75–83.
- Hwang S, Lam M, Li C, Shen T (1986): Release of platelet activating factor and its involvement in the firt phase of carrageenan rat foot oedema. Eur J Pharmacol 120: 33–41.
- Jong SC, Birmingham JM (1992): Medicinal benefits of the mushroom Ganoderma. Adv Appl Microbiol 37: 101–134.
- Kim HW, Kim BK (1999): Biomedical triterpenoids of Gano-derma lucidum (Curt. :Fr.) P. Karst (Aphyllophoromyce-tideae). Int J Med Mushr 1: 121–138.
- Koyama K, Imaizumi T, Akiba M, Kinoshita K, Takahashi K, Suzuki A, Yano S, Honk S, Watanabe K, Naoi Y (1997): Anti-nociceptive components of Ganoderma lucidum. Planta Med 63: 224–227.
- Larsen GL, Henson PM (1983): Mediators of inflammation. Ann Rev Immunol 1: 335–339.
- Liu GT (1999): Recent advances in research of pharmacology and clinical application of Ganoderma P. Karst species (Aphyllophoromycetideae) in China. Inter J Med Mushr 1: 63–67.
- Lo TN, Almeida AP, Beaven MA (1982): Dextran and car-rageenan evoke different inflammatory response in rat with respect to composition of infiltrates and effect of indometacin. J Pharmacol Exp Ther 221: 261–267.
- Nishitoba T, Salo H, Shirasu S, Sakamura S (1986): Evidence on the strain specific terpenoid pattern of Ganoderma lucidum. Agric Biol Chem 50: 2151–2154.
- Shiao MS, Lee KK, Lin LI, Wang CT (1994): Natural products and biological activities of the Chinese medicinal fungus Ganoderma lucidum. In: Ho CT, Osawa T, Huang MT, Roem RT, eds., Food Phytochemicals II. Teas, Spices and Herbs. Washington DC American Chemical Society, pp. 342–354.
- Vane J, Booting R (1987): Inflammation and the mechanism of action of anti-inflammatory drugs. FASEB J 1: 89–96.
- Wheeler-Aceto H, Cowan A (1991): Neurogenic and tissue mediated components of formalin-induced oedema. Agents Actions 34: 264–268.